(Total Views: 350)
Posted On: 09/04/2019 3:05:18 PM
Post# of 153994
Today Proactive video ;Thank you Lorbas,
—0:40.,,,Gilead failed with NASH
—-1:10..,, so , most of antiviral drugs in hiv especially Tenofovir , which is everywhere producing fibrosis of the liver ,so all HAART regimen should include CCR5 antagonist to stop that .. !!!!!!!!!!!!!!!
—1:50 about 50-60,000.00 to apply for INH..
—.2:10...GvHD patient most probably injected this month .
—2:28 when we have such a safety profile like Leronlimab we don’t need to go to phase 1, we going to phase 2
—3:26 .. In phase 2 for NASH we be looking for fibrosis in the liver , is lower or gone , and then we apply for BTD
Then talking how important NASH can be and we getting small funding for job to get done now , only what we need ,
BLA this year , earning Q 2 next year.
Than also licensing or some type of merger ..
—0:40.,,,Gilead failed with NASH
—-1:10..,, so , most of antiviral drugs in hiv especially Tenofovir , which is everywhere producing fibrosis of the liver ,so all HAART regimen should include CCR5 antagonist to stop that .. !!!!!!!!!!!!!!!
—1:50 about 50-60,000.00 to apply for INH..
—.2:10...GvHD patient most probably injected this month .
—2:28 when we have such a safety profile like Leronlimab we don’t need to go to phase 1, we going to phase 2
—3:26 .. In phase 2 for NASH we be looking for fibrosis in the liver , is lower or gone , and then we apply for BTD
Then talking how important NASH can be and we getting small funding for job to get done now , only what we need ,
BLA this year , earning Q 2 next year.
Than also licensing or some type of merger ..
(0)
(0)
